Primary record
N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]dodecanamide
- 库存
- 1,530 克
- 纯度
- 98.9 %
- CAS
- 474943-80-1
化合物标识与属性
- CAS
- 474943-80-1
- PubChem CID
- 131675307
- SMILES
- CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O)O)O)NC(=O)CCCCCCCCCCC)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O)NC(=O)CCCCCCCCCCC
名称与同义词
- Lactosylceramide
- LacCer
- Cytolipin H
- CDw17 antigen
- MEC7YDL92Q
- 474943-80-1
- lactosyl-n-acylsphingosine
- UNII-MEC7YDL92Q
- RefChem:1082909
- Trihexosylceramide (d18:1/12:0)
- D-Lactosyl--1,1' N-lauroyl-D-erythro-sphingosine
- LacCer(d18:1/12:0)
- N-Lignoceryl sphingosyl lactoside
- CHEBI:230377
- C42H79NO13
- Gal-beta1->4Glc-beta1->1'Cer
- Lactosyl ceramide (d18:1/12:0)
- MFCD22416993
- HY-W341625
- D-Galactosyl-1,4-beta-D-glucosylceramide
- DA-78618
- c12 lactosyl(beta) ceramide (d18:1/12:0)
- CS-0452739
- D-lactosyl-beta-1,1' N-lauroyl-D-erythro-sphingosine
- N-(dodecanoyl)-1-b-lactosyl-sphing-4-enine
- N-(Dodecanoyl)-1-beta-lactosyl-sphing-4-ene
- beta-D-Galactosyl-1,4-beta-D-glucosylceramide
- G91246
- N-(dodecanoyl)-1-beta-lactosyl-sphing-4-enine
- delta-Galactosyl-1,4-beta-delta-glucosylceramide
- beta-delta-Galactosyl-1,4-beta-delta-glucosramide
- D-lactosyl-1,1' N-lauroyl-D-erythro-sphingosine
- D-lactosyl-?-1,1' N-lauroyl-D-erythro-sphingosine
- D-lactosyl-|A-1,1 N-lauroyl-D-erythro-sphingosine
- N-[(E,2S,3R)-1-[(2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]dodecanamide
- Beta-delta-Galactosyl-1,4-beta-delta-Glucosylceramide
- D-lactosyl-|A-1,1' N-lauroyl-D-erythro-sphingosine
- N-(DODECANOYL)-1-.BETA.-LACTOSYL-SPHING-4-ENE
- 1-O-(4-O-b-D-galactopyranosyl-b-D-glucopyranosyl)-Ceramide
- 1-O-(4-O-beta-D-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- 1-O-(4-O-beta-delta-galactopyranosyl-beta-delta-glucopyranosyl)-Ceramide
- 1ylce-O-(4-O-beta-delta-Galactopyranosyl-beta-glucopyranosyl)ceramide
- Dodecanamide, N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- N-((2R,3R)-1-((2S,3S,4S,5S,6S)-6-(Hydroxymethyl)-5-((2R,3S,4R,5S,6S)-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl)oxy-3,4-bis(oxidanyl)oxan-2-yl)oxy-3-oxidanyl-octadec-4-en-2-yl)dodecanamide
- N-((2S,3R,4E)-1-(((2R,3R,4R,5S,6R)-3,4-Dihydroxy-6-(hydroxymethyl)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)oxan-2-yl)oxy)-3-hydroxyoctadec-4-en-2-yl)dodecanamide
- CDH
- DODECANAMIDE, N-((1S,2R,3E)-1-(((4-O-.BETA.-D-GALACTOPYRANOSYL-.BETA.-D-GLUCOPYRANOSYL)OXY)METHYL)-2-HYDROXY-3-HEPTADECEN-1-YL)-
- Dodecanamide, N-((1S,2R,3E)-1-(((4-o-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy)methyl)-2-hydroxy-3-heptadecen-1-yl)-
- Dodecanamide,N-[(1S,2R,3E)-1-[[(4-O-beta-D-galactopyranosyl-beta-D-glucopyranosyl)oxy]methyl]-2-hydroxy-3-heptadecen-1-yl]-
- N-[(E,1S,2R)-1-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxymethyl]-2-hydroxy-heptadec-3-enyl]dodecanamide
- N-[(E,2S,3R)-1-[(2R,5S)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,5R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3-hydroxyoctadec-4-en-2-yl]dodecanamide